Let us know. Catch every headline in your inbox ...

Researchers at the Max Planck Institute for Brain Research have mapped the molecular landscape of the mouse hippocampus, a ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...

Analyzing single-cell RNA sequencing (scRNA-seq) data is crucial for understanding complex biological processes and disease ...

This study provides valuable insights into human valve development by integrating snRNA-seq and spatial transcriptomics to characterize cell populations and regulatory programs in the embryonic and ...

Wave’s RNA editor resulted in protein levels that were “exceedingly close” to what investors were expecting, but nevertheless fell short of that bar, according to analysts at Truist Securities. Wave ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic. “[Donidalorsen] represents a significant advance for people living with HAE ...

We’re celebrating 180 years of Scientific American. Explore our legacy of discovery and look ahead to the future. In 1957, just four years after Francis Crick and other scientists solved the riddle of ...

Another Massachusetts biotech has reached the end of the road. NextRNA Therapeutics has begun winding down operations with a “heavy heart,” the company’s co-founder, president and CEO Dominique ...

When cells expire, they leave behind an activity log of sorts: RNA expelled into blood plasma that reveals changes in gene expression, cellular signaling, tissue injury and other biological processes.